Since then many studies have documented CD46 upregulation in multiple myeloma (MM) and in a host of solid tumors, including ovarian, breast, cervical, colorectal, prostate, bladder, and others (5, 6). This evidence concerns the gene CD46 and Miyoshi myopathy.